These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6002050)

  • 41. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
    J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Problems in the surgical treatment of malignant melanomas].
    Köhnlein HE; Troetschler H
    Chirurg; 1974 Aug; 45(8):356-62. PubMed ID: 4418183
    [No Abstract]   [Full Text] [Related]  

  • 44. Isolated limb perfusion in regional melanoma.
    Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
    Surg Oncol Clin N Am; 2006 Apr; 15(2):373-84. PubMed ID: 16632221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of the complex treatment of melanoblastoma of the lower extremities].
    Levin AO
    Vopr Onkol; 1975; 21(8):17-21. PubMed ID: 1166647
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experience in the management of malignant tumors of the limbs using regional perfusion with cytostatics].
    Tomsů M
    Cas Lek Cesk; 1967 Jun; 106(24):652-5. PubMed ID: 5588238
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of malignant melanomas with perfusion in extracorporeal circulation].
    Roselló Ochoa E
    Actas Dermosifiliogr; 1970; 61(11):397-9. PubMed ID: 5526740
    [No Abstract]   [Full Text] [Related]  

  • 48. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
    Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
    J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical quality control in an international randomized clinical trial.
    Schraffordt Koops H
    Eur J Surg Oncol; 1992 Dec; 18(6):525-9. PubMed ID: 1478285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
    Alrich EM; Manwaring JL; Horsley JS
    Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
    [No Abstract]   [Full Text] [Related]  

  • 51. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
    McBride CM; Sugarbaker EV; Hickey RC
    Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Melanoma recurrence confined to a free flap after isolated limb perfusion.
    Roberts CE; Harris PA; Thomas JM
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):e277-9. PubMed ID: 18463014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of malignant melanoblastoma of the skin].
    Oldhoff J; Koudstaal J; van Goch JJ
    Ned Tijdschr Geneeskd; 1968 Aug; 112(32):1433-8. PubMed ID: 5679594
    [No Abstract]   [Full Text] [Related]  

  • 54. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM; Takkenberg B; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Hart GA; Kroon BB
    Ann Surg Oncol; 2004 May; 11(5):491-9. PubMed ID: 15078633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
    Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
    Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNF dose reduction in isolated limb perfusion.
    Grünhagen DJ; de Wilt JH; van Geel AN; Graveland WJ; Verhoef C; Eggermont AM
    Eur J Surg Oncol; 2005 Nov; 31(9):1011-9. PubMed ID: 16099618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's witness.
    van Akkooi AC; Golab-Schwarz HD; Eggermont AM; van Geel AN
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):408-10. PubMed ID: 16829108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.